277 related articles for article (PubMed ID: 6972729)
21. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
Fuchs PC; Jones RN; Barry AL; Thornsberry C
Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
Jones RN; Wilson HW
Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
[TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1982 Jan; 21(1):180-7. PubMed ID: 6979306
[TBL] [Abstract][Full Text] [Related]
25. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker CN; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
[TBL] [Abstract][Full Text] [Related]
26. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.
Jones RN; Erwin ME
Antimicrob Agents Chemother; 1992 Jan; 36(1):233-8. PubMed ID: 1590695
[TBL] [Abstract][Full Text] [Related]
27. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
28. Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds.
Wise R; Andrews JM; Bedford KA
Antimicrob Agents Chemother; 1980 May; 17(5):884-9. PubMed ID: 6772097
[TBL] [Abstract][Full Text] [Related]
29. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Phillips I; Warren C; Shannon K; King A; Hanslo D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporin.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1983 Sep; 24(3):375-82. PubMed ID: 6605719
[TBL] [Abstract][Full Text] [Related]
31. Comparative in vitro activity of ceftriaxone against clinical bacterial isolates in Nigeria.
Obaseiki-Ebor EE; Afonya TC; Oyaide SM
Chemotherapy; 1985; 31(2):130-7. PubMed ID: 3872779
[TBL] [Abstract][Full Text] [Related]
32. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics.
Jones RN; Barry AL
Rev Infect Dis; 1983; 5 Suppl 1():S108-26. PubMed ID: 6221381
[TBL] [Abstract][Full Text] [Related]
33. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
Neu HC; Chin NX
Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
[TBL] [Abstract][Full Text] [Related]
34. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
Neu HC; Chin NX; Labthavikul P
Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.
Yu KW; Chin NX; Neu HC
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):652-9. PubMed ID: 1396779
[TBL] [Abstract][Full Text] [Related]
36. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.
Jones RN; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S300-15. PubMed ID: 6294779
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
38. In vitro evaluation of Ro 13-9904.
Hinkle AM; Bodey GP
Antimicrob Agents Chemother; 1980 Oct; 18(4):574-8. PubMed ID: 6778383
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
Neu HC; Chin NX; Labthavikul P
Antimicrob Agents Chemother; 1986 Sep; 30(3):423-8. PubMed ID: 3490827
[TBL] [Abstract][Full Text] [Related]
40. In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.
Jones RN; Barry AL; Thornsberry C; Wilson HW
Antimicrob Agents Chemother; 1981 Dec; 20(6):760-8. PubMed ID: 6275785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
